Cartesian Therapeutics
RNAC
$26.43
Share price
0.34%
Change (1 day)
2,281.08%
Change (1 year)
Categories
P/S ratio for Cartesian Therapeutics (RNAC)
P/S ratio as of May 2024 (TTM): 18.0
According to Cartesian Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 18.026. At the end of 2023 the company had a P/S ratio of 4.29.
P/S ratio history for Cartesian Therapeutics from 2016 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.29 | 175.01% |
| 2022 | 1.56 | -67.05% |
| 2021 | 4.74 | -75.99% |
| 2020 | 19.7 | -35.88% |
| 2019 | 30.8 | -53.52% |
| 2018 | 66.2 | -93.75% |
| 2017 | > 1000 | 2642.75% |
| 2016 | 38.6 |